Artificial Intelligence (AI) Enabled Medical Imaging Market 2024 To Reach USD 16.20 BILLION BY 2030 at Rate of 25.9% by 2030

The Global Artificial Intelligence (AI) Enabled Medical Imaging Market size was valued at around USD 3.23 billion in 2023 & is projected to reach around USD 16.20 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 25.9% during the forecast period, i.e., 2024-30                          

Key Findings of the Study: Artificial Intelligence (AI) Enabled Medical Imaging Market

Global Artificial Intelligence (AI) Enabled Medical Imaging Market Driver: Shortage of Radiologists Necessitating AI Adoption

The market revenue growth has been primarily credited to the shortage of radiologists to cater to the growing global patient population pool. This, thereby affects the quality and efficiency of diagnostic services and fosters the acceptance and utilization of artificial intelligence (AI) enabled medical imaging. Hence, its applications in radiology would augment the competencies of radiologists leading to faster and more accurate diagnoses.

Furthermore, because imaging biomarkers are crucial for the early diagnosis, monitoring, and detection of diseases, their use in clinical settings is increasing. However, the enormous volumes of data produced by imaging biomarkers would need the implementation of advanced technology for analysis and interpretation, requiring additional manual work. As a result, there is an increasing dependence on artificial intelligence (AI) in medical imaging due to the rising integration of imaging biomarkers and the severe radiologists shortage. Because of this, there will be a continued increase in demand in the future years for AI-enabled imaging solutions. So, if such a shortage of skilled radiologists continues, the AI-enabled medical imaging market is anticipated to grow & flourish in the coming years at a steady growth rate.

Access Free Sample Report – https://www.marknteladvisors.com/query/request-sample/global-artificial-intelligence-enabled-medical-imaging-market.html

Scope of the Report and Artificial Intelligence (AI) Enabled Medical Imaging Market Segmentation

By Component

-Hardware

-Software

–Perpetual Software License

–Subscription Software License

–Pay as You Go Software License

By Workflow

-Image Analysis

-Image Acquisition

-Detection

-Reporting & Communication

-Diagnosis & Treatment Decision Support

-Predictive Analysis & Risk Assessment

-Equipment Maintenance

-Triage

By Technology

-Deep Learning

-Machine Learning

-Computer Vision

-Natural Language Processing (NLP)

-Others

By Therapeutic Application

-Specialty Imaging

–Cardiology

–Oncology

—Lung Cancer

—Breast Cancer

—Other Cancers

–Neurology

–Respiratory

–Orthopedics

–Others

-General Imaging

By Deployment

-Cloud

-On-Premise

By Modality

-Computed Tomography

-Magnetic Resonance

-Ultrasound

-X-Ray

-Mammography

-Multimodality Imaging Systems

-Others

  • Computed Tomography (CT) segment held the largest share of the Global Artificial Intelligence (AI) Enabled Medical Imaging Market.

By End Users

-Hospitals

-Clinics

-Diagnostics Centers

-Others

Top leading companies in the Artificial Intelligence (AI) Enabled Medical Imaging Market includes:

Aidoc, Arterys Inc., Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, ContextVision AB, EnvoyAI, Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Mirada Medical Limited, NVIDIA Corporation, Nuance Communications, Inc., Resonance Health Ltd., Samsung Electronics Co., Ltd., and others

Artificial Intelligence (AI) Enabled Medical Imaging Market Development

  • 2024: GE HealthCare announced an agreement to acquire MIM Software Inc., a Cleveland-based provider of AI imaging-analysis software.
  • 2023: Philips introduced new AI-enabled solutions, including EPIQ Elite 10.0 and Philips Affiniti ultrasound systems, BlueSeal MR Mobile system, and the Philips HealthSuite Imaging PACS solution in the US.

For more detailed information about the Artificial Intelligence (AI) Enabled Medical Imaging market report, click here – https://www.marknteladvisors.com/research-library/global-artificial-intelligence-enabled-medical-imaging-market.html                           

Geographical analysis:

North America: The US, Canada, Mexico

Europe: Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia Pacific

South America: Brazil, Rest of South America

Middle East & Africa: The UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa

  • The Global Artificial Intelligence (AI) Enabled Medical Imaging Market is dominated by North America with a major market share.

Note: If you require specific information not covered in the current report, we can provide it through customized option

Related Reports: –

https://industrytoday.co.uk/market-research-industry-today/uae-gluten-free-products-market-expected-to-grow-significantly-with-a-75-cagr-by-2028-bobs-red-mill-carrefour-uae-earth-goods

https://industrytoday.co.uk/market-research-industry-today/latin-america-abrasives-market-witness-highest-growth-at-a-cagr-of-56-by-2028

https://industrytoday.co.uk/market-research-industry-today/energy-bar-market-showcase-innovative-solutions-to-gain-incredible-demand

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Emailsales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India